• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.55 Down 0.01(0.39%) Dec 19, 4:00PM EST
    |After Hours : 2.55 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Prev Close:2.56
    Open:2.61
    Bid:2.37 x 200
    Ask:2.80 x 100
    1y Target Est:11.00
    Beta:1.05
    Next Earnings Date:N/A
    Day's Range:2.50 - 2.69
    52wk Range:2.08 - 8.35
    Volume:1,017,809
    Avg Vol (3m):814,103
    Market Cap:142.13M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 0.39%142.13M
    LLYDown 0.07%77.44B
    NVSUp 0.04%228.83B
    SNYDown 0.90%121.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,426.84
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.73
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback